Cargando…

Calculation of the pharmacogenomics benefit score for patients with medication-related problems

Unexpected poor efficacy and intolerable adverse effects are medication-related problems that may result from genetic variation in genes encoding key proteins involved in pharmacokinetics or pharmacodynamics. Pharmacogenomic (PGx) testing can be used in medical practice “pre-emptively” to avoid futu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Polasek, Thomas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196203/ https://www.ncbi.nlm.nih.gov/pubmed/37214415 http://dx.doi.org/10.3389/fgene.2023.1152585

Ejemplares similares

Consistent terminology for medication-related problems in pharmacogenomic cases
por: Polasek, Thomas M., et al.
Publicado: (2023)

Polygenic risk scores in pharmacogenomics: opportunities and challenges—a mini review
por: Simona, Aurélien, et al.
Publicado: (2023)

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
por: Klein, Kathrin, et al.
Publicado: (2013)

Pharmacogenomics Guided Prescription Changes Improved Medication Effectiveness in Patients With Mental Health-Related Disability: A Retrospective Cohort Analyses
por: Ahmed, Sanjida, et al.
Publicado: (2021)

Pharmacogenomics and health disparities, are we helping?
por: Shaaban, Sherin, et al.
Publicado: (2023)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report
por: Prather, April, et al.
Publicado: (2022)

Response to: “Consistent terminology for medication-related problems in pharmacogenomic cases”
por: Korchia, Theo, et al.
Publicado: (2023)

Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019)

A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics
por: Brown, Chad, et al.
Publicado: (2011)

Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021)

Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs
por: Trinh, Hoang Kim Tu, et al.
Publicado: (2021)

Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022)

An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis
por: David, Victoria, et al.
Publicado: (2021)

Editorial: The role of pharmacogenomics in addressing health disparities: the path, the promise, and the barriers
por: Roman, Youssef M.
Publicado: (2023)

Addressing disparities in pharmacogenomics through rural and underserved workforce education
por: Brown, Jacob T., et al.
Publicado: (2023)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021)

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
por: Abdelhalim, Habiba, et al.
Publicado: (2022)

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Calculating Polygenic Risk Scores (PRS) in UK Biobank: A Practical Guide for Epidemiologists
por: Collister, Jennifer A., et al.
Publicado: (2022)

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
por: Mroz, Pawel, et al.
Publicado: (2021)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Pharmacogenomic variabilities in geo-ancestral subpopulations and their clinical implications: Results of collaborations with Hmong in the United States
por: Sun, Boguang, et al.
Publicado: (2023)

Impute.me: An Open-Source, Non-profit Tool for Using Data From Direct-to-Consumer Genetic Testing to Calculate and Interpret Polygenic Risk Scores
por: Folkersen, Lasse, et al.
Publicado: (2020)

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
por: Mostafa, Sam, et al.
Publicado: (2021)

Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer
por: Kong, Weiqi, et al.
Publicado: (2023)

Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
por: Tafazoli, Alireza, et al.
Publicado: (2023)

Pharmacogenomic testing and antidepressant response: problems and promises
por: Smith, Tawny L., et al.
Publicado: (2020)

Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients
por: Zou, Yuantao, et al.
Publicado: (2022)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Medication reconciliation to support pharmacogenomics implementation
por: Mosley, Scott A., et al.
Publicado: (2022)

Review of Hmong-Related Health Problems: A Quick Guide for Healthcare Providers
por: Ali, Ali H, et al.
Publicado: (2020)

Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol
por: Peters, Jaime L, et al.
Publicado: (2015)

An Efficient Method to Calculate Genomic Prediction Accuracy for New Individuals
por: Ferdosi, Mohammad H., et al.
Publicado: (2019)

Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2021)

A composite score based on immune-related gene prognostic index and m(6)A risk score of head and neck squamous cell carcinoma
por: Yang, Yizhou, et al.
Publicado: (2023)

The computational implementation of a platform of relative identity-by-descent scores algorithm for introgressive mapping
por: Cui, Bo, et al.
Publicado: (2023)

Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma
por: Lin, Jianwei, et al.
Publicado: (2021)

Identification of the Transcription Co-Factor–Related Gene Signature and Risk Score Model for Osteosarcoma
por: Jin, Zhijian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5uhp42h8m7qbqud6l8mhr7m7cu